AKT1 and Alzheimer disease: However, our results impart important information regarding modulation of the ER, PI3K/AKT, and GSK-3β signaling pathways by naringin, thus providing a theoretical basis for future studies examining naringin's neuroprotective effects and viability as an AD therapeutic agent.